Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines
about
Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliveryPeptide Vaccine: Progress and ChallengesEnhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection.Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.Recent progress toward development of vaccines against conception.Recent advances in peptide-based subunit nanovaccines.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Investigation of structure-activity relationships of synthetic anti-gonadotropin releasing hormone vaccine candidates.Structure-function relationships of protein-lipopeptide complexes and influence on immunogenicity.Fabrication of chitosan/gallic acid 3D microporous scaffold for tissue engineering applications.Designing improved poly lactic-co-glycolic acid microspheres for a malarial vaccine: incorporation of alginate and polyinosinic-polycytidilic acid.Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis.Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune PotentiationInteractions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
P2860
Q26766552-5AC215DD-CB82-4E76-9DAE-0D234F45E2DAQ26851329-1A94C0F7-981F-407C-9C4C-75F84B31481FQ34700107-57F4C8AD-4D6C-4AF3-87A3-4BA8ACD88835Q37671847-95E9B1D8-4C47-4435-84AA-986CCAC8E078Q38066148-E8F49FC6-5258-462E-BA7B-0E091FAF9B5CQ38168910-E74D4D8E-CCD4-401E-B656-460CF2FBC653Q38296076-233C090C-A8D6-4BAB-BE9D-1AB1C0280A46Q38418305-729793C1-6A33-4D4B-8CCF-BC1D55889EE8Q38895112-6E144D99-BDD6-4513-9100-725E3F6052B0Q40130682-17D511B5-7583-4055-B23E-DA8CB0EBAA59Q42816177-5152C5F5-BB28-4906-B166-24DB3E616FA6Q47862273-1EEFC3F9-ECB9-4209-AB5B-3BF3987EAB42Q55224227-AF5EA784-3F7B-4FF1-BF5E-5157A8C59EA6Q56993652-C7C4746A-BE5F-4D88-84A3-8BD7C85A4ED6Q57492118-5CEB4FB5-6FEB-4556-96B0-46BA9D8D19B7
P2860
Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines
description
im Dezember 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 December 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2011
@uk
name
Chitosan Microparticles and Na ...... d Immunocontraceptive Vaccines
@en
Chitosan Microparticles and Na ...... d Immunocontraceptive Vaccines
@nl
type
label
Chitosan Microparticles and Na ...... d Immunocontraceptive Vaccines
@en
Chitosan Microparticles and Na ...... d Immunocontraceptive Vaccines
@nl
prefLabel
Chitosan Microparticles and Na ...... d Immunocontraceptive Vaccines
@en
Chitosan Microparticles and Na ...... d Immunocontraceptive Vaccines
@nl
P50
P356
P1476
Chitosan microparticles and na ...... d immunocontraceptive vaccines
@en
P2093
David Mainwaring
Weiguang Zeng
P356
10.1021/MP200264M
P407
P577
2011-12-16T00:00:00Z